Fundraising Fox

Apriori Bio

1 known investors

aprioribio.com ↗

Apriori Bio develops a platform, Octavia, that experimentally maps viral evolution to predict future variants, using those insights to design prospective vaccines intended to protect across immune histories, age groups, and regions. The company operates in vaccine development and biotechnology.

BiotechDeep TechHealthtech

Investors · 1

Flagship PioneeringCambridge · $500K – $10M

In the news

Flagship-backed Apriori Bio lays off employees, shifts focus to pipeline developmentfiercebiotech.com · Mar 2025Flagship Pioneering Appoints Craig Williams as CEO-Partner and Chief Executive Officer of Apriori Bioprnewswire.com · Nov 2024Apriori Bio Raises $1.1M Funding | citybizcitybiz.co · Jul 2024MA-based Apriori Bio Raises $1.1M Funding from CEPIstartuprise.io · Jul 2024Flagship-backed startup Apriori Bio aims to 'close off the escape routes' for evolving viruses - Boston Business Journalbizjournals.com · Jul 2022

Frequently asked questions

What does Apriori Bio do?
Apriori Bio develops a platform, Octavia, that experimentally maps viral evolution to predict future variants, using those insights to design prospective vaccines intended to protect across immune histories, age groups, and regions. The company operates in vaccine development and biotechnology.
Who are Apriori Bio's investors?
Apriori Bio's investors include Flagship Pioneering.